Experiences with monoclonal antibody therapy for allergic asthma

Journal of Allergy and Clinical Immunology

Volumn 108, Issue 2 SUPPL., 2001, Pages

  Boushey H A , Jr ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Allergic disease; Anti IgE; Asthma; Atopy; IgE; Omalizumab

Indexed keywords

CORTICOSTEROID; FC RECEPTOR; IMMUNOGLOBULIN E; MONOCLONAL ANTIBODY; OMALIZUMAB; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ALLERGIC ASTHMA; BASOPHIL; BINDING AFFINITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BINDING SITE; DRUG RECEPTOR BINDING; DRUG SAFETY; HUMAN; IMMUNE RESPONSE; MAST CELL; MULTICENTER STUDY; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; RECEPTOR DENSITY; REVIEW; RISK BENEFIT ANALYSIS; SCHOOL CHILD; TREATMENT OUTCOME;

EID: 0034864618     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2001.116434     Document Type: Article

References (19)

1. Identification of e-antibodies as a carrier of reaginic activity
2. Induction of passive cutaneous anaphylaxis in monkeys by human gamma-E antibody
3. Relation between airway responsiveness and serum IgE in children with asthma and in apparently normal children
4. Association of asthma with serum IgE levels and skin-test reactivity to allergens
5. Relationship between serum IgE and airway responsiveness in adults with asthma
6. IgE-dependent antigen focusing by human B lymphocytes is mediated by the low-affinity receptor for IgE
7. Effect of aerosolized anti-IgE (E25) on airway responses to inhaled allergen in asthmatic subjects
8. Effects of anti-IgE in asthmatic subjects
9. Humanization of an antibody directed against IgE
10. The binding site on human immunoglobulin E for its high affinity receptor
11. The pharmacological basis of anti-IgE therapy
12. Characterization of complex formation by humanized anti-IgE monoclonal antibody and monoclonal human IgE
13. Therapeutic potential of anti-IgE antibodies
14. Tissue distribution and complex formation with IgE of an anti-IgE antibody after intravenous administration in cynomolgus monkeys
15. Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response
16. The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects
17. Down-regulation of FcεRI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody
18. Treatment of allergic asthma with monoclonal anti-IgE antibody
19. RhuMAb-E25, a novel therapy for the treatment of allergic asthma (AA)